<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:00:32Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4819692" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4819692</identifier><datestamp>2016-04-28</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="letter">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">FEBS Lett</journal-id>
      <journal-id journal-id-type="iso-abbrev">FEBS Lett</journal-id>
      <journal-id journal-id-type="doi">10.1002/(ISSN)1873-3468</journal-id>
      <journal-id journal-id-type="publisher-id">FEB2</journal-id>
      <journal-title-group>
        <journal-title>Febs Letters</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0014-5793</issn>
      <issn pub-type="epub">1873-3468</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4819692</article-id>
      <article-id pub-id-type="pmcid">PMC4819692</article-id>
      <article-id pub-id-type="pmc-uid">4819692</article-id>
      <article-id pub-id-type="pmid">26846330</article-id>
      <article-id pub-id-type="doi">10.1002/1873-3468.12089</article-id>
      <article-id pub-id-type="publisher-id">FEB212089</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Research Letter</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Research Letters</subject>
          <subj-group subj-group-type="heading">
            <subject>Structural biology (Editor's choice)</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structure of glycosylated <styled-content style="fixed-case">NPC</styled-content>1 luminal domain C reveals insights into <styled-content style="fixed-case">NPC</styled-content>2 and Ebola virus interactions</article-title>
        <alt-title alt-title-type="left-running-head">Y. Zhao <italic>et al</italic>.</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="feb212089-cr-0001" contrib-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>Yuguang</given-names>
          </name>
          <xref ref-type="aff" rid="feb212089-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="feb212089-cr-0002" contrib-type="author">
          <name>
            <surname>Ren</surname>
            <given-names>Jingshan</given-names>
          </name>
          <xref ref-type="aff" rid="feb212089-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="feb212089-cr-0003" contrib-type="author">
          <name>
            <surname>Harlos</surname>
            <given-names>Karl</given-names>
          </name>
          <xref ref-type="aff" rid="feb212089-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="feb212089-cr-0004" contrib-type="author" corresp="yes">
          <name>
            <surname>Stuart</surname>
            <given-names>David I.</given-names>
          </name>
          <xref ref-type="aff" rid="feb212089-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="feb212089-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="feb212089-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Division of Structural Biology</named-content>
        <institution>University of Oxford</institution>
        <named-content content-type="city">Headington</named-content>
        <named-content content-type="city">Oxford</named-content>
        <country country="GB">UK</country>
      </aff>
      <aff id="feb212089-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <institution>Diamond Light Source Ltd</institution>
        <named-content content-type="city">Didcot</named-content>
        <country country="GB">UK</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
D. I. Stuart, Division of Structural Biology, University of Oxford, The Henry Wellcome Building for Genomic Medicine, Headington, Oxford OX3 7BN, UK<break/>
Fax: +44 (0)1865 287501<break/>
Tel: +44 (0)1865 287567<break/>
Eâmail: <email>dave@strubi.ox.ac.uk</email><break/></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>2</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <volume>590</volume>
      <issue>5</issue>
      <issue-id pub-id-type="doi">10.1111/feb2.2016.590.issue-5</issue-id>
      <fpage>605</fpage>
      <lpage>612</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>27</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 Federation of European Biochemical Societies <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2016 The Authors. FEBS Letters published by John Wiley &amp; Sons Ltd on behalf of Federation of European Biochemical Societies.</copyright-statement>
        <license license-type="creativeCommonsBy">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:FEB2-590-605.pdf"/>
      <abstract id="feb212089-abs-0001">
        <p>Niemannâpick type C1 (<styled-content style="fixed-case">NPC</styled-content>1) is an endo/lysosomal membrane protein involved in intracellular cholesterol trafficking, and its luminal domain C is an essential endosomal receptor for Ebola and Marburg viruses. We have determined the crystal structure of glycosylated <styled-content style="fixed-case">NPC</styled-content>1 luminal domain C and find all seven possible sites are glycosylated. Mapping the disease mutations onto the glycosylated structure reveals a potential binding face for <styled-content style="fixed-case">NPC</styled-content>2. Knowledgeâbased docking of <styled-content style="fixed-case">NPC</styled-content>1 onto Ebola viral glycoprotein and sequence analysis of filovirus susceptible and refractory species reveals four critical residues, H418, Q421, F502 and F504, some or all of which are likely responsible for the speciesâspecific susceptibility to the virus infection.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="feb212089-kwd-0001">cholesterol transport</kwd>
        <kwd id="feb212089-kwd-0002">Ebola virus receptor</kwd>
        <kwd id="feb212089-kwd-0003">Ebola virus susceptibility</kwd>
        <kwd id="feb212089-kwd-0004">NiemannâPick disease type C</kwd>
        <kwd id="feb212089-kwd-0005"><styled-content style="fixed-case">NPC</styled-content>1</kwd>
        <kwd id="feb212089-kwd-0006"><styled-content style="fixed-case">NPC</styled-content>2</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>EU seventh Framework Programme (FP7)</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Wellcome Trust</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>UK Medical Research Council</funding-source>
          <award-id>MR/N00065X/1</award-id>
          <award-id>090532/Z/09/Z</award-id>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="8"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>feb212089</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>March 2016</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.8.5 mode:remove_FC converted:01.04.2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <fn-group id="feb212089-ntgp-0002">
        <fn id="feb212089-note-1001">
          <p>Edited by HansâDieter Klenk</p>
        </fn>
      </fn-group>
    </notes>
  </front>
  <body>
    <sec id="feb212089-sec-1526">
      <title>Abbreviations</title>
      <p>
<bold>DC</bold> domain C</p>
      <p>
<bold>GP</bold> glycoprotein</p>
      <p>
<bold>NPC1</bold> NiemannâPick type C1</p>
      <p>
<bold>NTD</bold> Nâterminal domain A</p>
      <p>
<bold>TPC2</bold> twoâpore calcium channel protein 2</p>
    </sec>
    <sec id="feb212089-sec-0001">
      <p>NiemannâPick disease type C is a fatal, neurodegenerative lipid storage disorder resulting from autosomal recessively inherited loss of function mutations in genes NPC1 or NPC2 <xref rid="feb212089-bib-0001" ref-type="ref">1</xref>. The NPC1 gene encodes an endosomal/lysosomal 13âpass transmembrane protein with three large luminal domains, namely a cholesterolâbinding Nâterminal domain A (NTD or loop1), domain C (DC or loop2) and domain I (loop3). While NPC2 is a small secreted cholesterolâbinding glycoprotein, it can be translocated to endosomes/lysosomes through its Mannoseâ6âphosphateâmodified glycans <xref rid="feb212089-bib-0002" ref-type="ref">2</xref>. Within endosomes/lysosomes, NPC2 traps unesterified cholesterol in a hydrophobic pocket, and hands this over to NPC1 by attaching to luminal domain C and then transferring cholesterol to the Nâterminal cholesterolâbinding domain <xref rid="feb212089-bib-0003" ref-type="ref">3</xref>, <xref rid="feb212089-bib-0004" ref-type="ref">4</xref>. Loss of function mutations in either NPC1 or NPC2 lead to the accumulation of cholesterol and glycosphingolipids in various tissues and organs, resulting in NiemannâPick disease neuroâdegeneration as well as lung and liver dysfunction <xref rid="feb212089-bib-0001" ref-type="ref">1</xref>.</p>
      <p>Apart from its essential role in cholesterol transport, NPC1 has been identified as a critical host entry receptor for filoviruses <xref rid="feb212089-bib-0005" ref-type="ref">5</xref>, <xref rid="feb212089-bib-0006" ref-type="ref">6</xref>, interacting directly with the viral glycoprotein (GP). Filoviruses, such as Ebola virus and Marburg virus cause haemorrhagic fever with high mortality <xref rid="feb212089-bib-0007" ref-type="ref">7</xref>. Filovirus cell attachment is initiated through nonspecific attachment, followed by internalization. When virus containing vesicles are delivered to endosomes, protease cathepsin B/L removes the GP1 cap and mucin domain, exposing the NPC1âbinding sites, and with help of additional factors, such as twoâpore calcium channel protein 2 (TPC2) <xref rid="feb212089-bib-0008" ref-type="ref">8</xref>, GP2 drives fusion of the viral and endosome membranes, releasing the viral genetic material into the host cell cytoplasm and initiating viral replication. Only the NPC1 luminal domain C is required for viral glycoprotein binding <xref rid="feb212089-bib-0005" ref-type="ref">5</xref>. Intriguingly it has recently been shown that EBOV assembly at the plasma membrane is cholesterolâdependent and cholesterol might therefore stabilize the virus particle <xref rid="feb212089-bib-0009" ref-type="ref">9</xref>.</p>
    </sec>
    <sec id="feb212089-sec-0002">
      <title>Materials and methods</title>
      <sec id="feb212089-sec-0003">
        <title>Protein production and crystallization</title>
        <p>Human NPC1 (UniProtKB/SwissâProt <ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org/uniprot/015118">015118</ext-link>) luminal domain C (residues Q387âD618) was PCR amplified from the cDNA (GE Dharmacon, Little Chalfont, UK; clone ID30340517) and cloned into a stable cell line vector pNeoSec <xref rid="feb212089-bib-0010" ref-type="ref">10</xref> in frame with a 3C protease cutting site, monoVenus fluorescent protein and ended with a Rhodopsin 1D4 tag. HEK293S GnTI(â) cells were cotransfected with a pNeoSecâNPC1âdomain C and a PhiC31 integrase expression vector (pCB92/pgkâÏC31). The polyclonal population resulting from G418 (1 mgÂ·mL<sup>â1</sup>) selection was cultured in roller bottles <xref rid="feb212089-bib-0011" ref-type="ref">11</xref>, <xref rid="feb212089-bib-0012" ref-type="ref">12</xref>. The conditioned medium containing secreted proteins was passed over Rhodopsin 1D4 antibodyâconjugated Sepharose 4 Fast Flow resin, and eluted by onâcolumn cutting of the tag using 3C protease. The eluted protein was polished on a Superdex 200 16/60 column, eluted in 10 m<sc>m</sc> Hepes pH 7.4, 150 m<sc>m</sc> NaCl buffer and concentrated to 5 mgÂ·mL<sup>â1</sup>. Crystallization screening was carried out using the sittingâdrop vapour diffusion method in 96âwell plates <xref rid="feb212089-bib-0013" ref-type="ref">13</xref> and crystals grown in 30% polyethylene glycol monoâethyl Ether 2000 and 0.1 <sc>m</sc> potassium thiocyanate. Good quality crystals were grown only from protein produced in Î²1,2â<italic>N</italic>âacetylglucosaminyltransferase I deficient (GNTIâ) human embryonic kidney cells, harbouring Man<sub>5</sub>GlcNAc<sub>2</sub> moieties, whereas Endo F1 deâglycosylated protein gave poor quality crystals.</p>
      </sec>
      <sec id="feb212089-sec-0004">
        <title>Data collection and structure determination</title>
        <p>Crystals were flash frozen in liquid nitrogen, and kept at â173 Â°C during Xâray data collection at I04, Diamond Light Source. Data images (exposure time 0.1 s with 30% beam transmission) of 0.1Â° rotation were recorded on a PILATUS 6M detector (Dectris, BadenâDÃ¤ttwil, Switzerland), at a wavelength of 1.7700 Ã for the sulfur SAD data set from seven crystals and 1.0675 Ã for the native data set from two crystals. Data images were indexed and integrated with Xia2â3dii <xref rid="feb212089-bib-0014" ref-type="ref">14</xref>. The crystals belong to space group <italic>C</italic>222<sub>1</sub> with two molecules in the crystal asymmetric unit. The structure was determined by sulfur SAD. Sulfur positions, two disulphides and a thiocyanate site, were determined by hkl2map <xref rid="feb212089-bib-0015" ref-type="ref">15</xref>. Phasing and initial modelling were done with Phenixâautosolve <xref rid="feb212089-bib-0016" ref-type="ref">16</xref>. Structure refinement and rebuilding used REFMAC <xref rid="feb212089-bib-0017" ref-type="ref">17</xref> and COOT <xref rid="feb212089-bib-0018" ref-type="ref">18</xref>. The final model, refined to 2.45 Ã resolution, has a Râfactor of 0.218 (Râfree, 0.243) with good stereochemistry. Data collection and structure refinement statistics are given in Table <xref rid="feb212089-tbl-0001" ref-type="table-wrap">1</xref>.</p>
        <table-wrap id="feb212089-tbl-0001" xml:lang="en" orientation="portrait" position="float">
          <label>Table 1</label>
          <caption>
            <p>Data collection and refinement statistics</p>
          </caption>
          <table frame="hsides" rules="groups">
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <tbody>
              <tr>
                <td align="left" colspan="3" rowspan="1">Data collection</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Data set</td>
                <td align="left" rowspan="1" colspan="1">SâSAD</td>
                <td align="left" rowspan="1" colspan="1">Native</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Wavelength (Ã)</td>
                <td align="left" rowspan="1" colspan="1">1.7700</td>
                <td align="left" rowspan="1" colspan="1">1.0675</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Space group</td>
                <td align="left" rowspan="1" colspan="1">
<italic>C</italic>222<sub>1</sub>
</td>
                <td align="left" rowspan="1" colspan="1">
<italic>C</italic>222<sub>1</sub>
</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Cell dimensions (Ã)</td>
                <td align="left" rowspan="1" colspan="1">
<italic>a</italic> = 88.1, <italic>b</italic> = 116.1, <italic>c</italic> = 147.8</td>
                <td align="left" rowspan="1" colspan="1">
<italic>a</italic> = 87.9, <italic>b</italic> = 115.9, <italic>c</italic> = 147.4</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Resolution (Ã)</td>
                <td align="left" rowspan="1" colspan="1">73.9â3.10 (3.18â3.10)</td>
                <td align="left" rowspan="1" colspan="1">70.0â2.45 (2.51â2.45)</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unique reflections</td>
                <td align="left" rowspan="1" colspan="1">14 134 (1035)</td>
                <td align="left" rowspan="1" colspan="1">28 062 (2038)</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">
<italic>R</italic>
<sub>merge</sub>
</td>
                <td align="left" rowspan="1" colspan="1">0.168 (0.720)</td>
                <td align="left" rowspan="1" colspan="1">0.063 (â)</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">CC<sub>50</sub>
</td>
                <td align="left" rowspan="1" colspan="1">1.000 (0.862)</td>
                <td align="left" rowspan="1" colspan="1">0.999 (0.354)</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">
<italic>&lt;I&gt;</italic>/&lt;Ï<italic>I&gt;</italic>
</td>
                <td align="left" rowspan="1" colspan="1">47.7 (4.1)</td>
                <td align="left" rowspan="1" colspan="1">13.3 (1.0)</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Completeness (%)</td>
                <td align="left" rowspan="1" colspan="1">99.9 (99.4)</td>
                <td align="left" rowspan="1" colspan="1">100.0 (99.9)</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Redundancy</td>
                <td align="left" rowspan="1" colspan="1">182.7 (16.9)</td>
                <td align="left" rowspan="1" colspan="1">26.5 (24.4)</td>
              </tr>
              <tr>
                <td align="left" colspan="3" rowspan="1">Refinement</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Resolution (Ã)</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">70.0â2.45</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No. reflections</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">26 647/1385</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">
<italic>R</italic>
<sub>work</sub>/<italic>R</italic>
<sub>free</sub>
</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0.218/0.243</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No. atoms</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">3941</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Average <italic>B</italic>âfactor (Ã<sup>2</sup>)</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">51</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">R.m.s. deviations</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td align="left" style="padding-left:15%" rowspan="1" colspan="1">Bond lengths (Ã)</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">0.008</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:15%" rowspan="1" colspan="1">Bond angles (Â°)</td>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">1.5</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="feb212089-note-0001">
              <p>Numbers in brackets refer to the highest resolution shell of data.</p>
            </fn>
          </table-wrap-foot>
          <permissions>
            <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
          </permissions>
        </table-wrap>
      </sec>
      <sec id="feb212089-sec-0005">
        <title>NPC1âEBOV GP docking</title>
        <p>The NPC1DCâEBOV GP (PDB id, <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CSY">3CSY</ext-link>
<xref rid="feb212089-bib-0019" ref-type="ref">19</xref>) docking was carried out with Haddock <xref rid="feb212089-bib-0020" ref-type="ref">20</xref> and GrammâX <xref rid="feb212089-bib-0021" ref-type="ref">21</xref>. Residues 502â504 from NPC1DC, and 86â88, 111â113 141â146 from EBOV GP were provided as the possible interacting residues for restraints. The glycan cap domain of EBOV GP and all the sugar residues of both proteins were removed for docking. The top solutions from both programs predicted a similar binding mode between the two proteins. The putative complex was checked by modelling all the glycosylation sites with Man9GlcNAc2 <xref rid="feb212089-bib-0010" ref-type="ref">10</xref> to see if the glycans hinder the formation of the complex and the structure of GP2 dislocated from GP1 after receptor binding modelled to see if it could present its fusion loop to the endo/lysosome membrane. Figures were prepared using PyMOL <xref rid="feb212089-bib-0022" ref-type="ref">22</xref>.</p>
      </sec>
    </sec>
    <sec id="feb212089-sec-0006">
      <title>Results and Discussion</title>
      <sec id="feb212089-sec-0007">
        <title>Overall structure of NPC1DC</title>
        <p>To better understand the cholesterol transport mechanism and the Ebola glycoprotein and receptor interaction at atomic level, we determined the structure of human NPC1 luminal domain C (NPC1DC) at 2.45 Ã resolution by Xâray crystallography, utilizing sulfur SAD phasing, refining the model to a reasonable Râfactor with good stereochemistry. Details of the data collection, structure determination and refinement statistics are given in Table <xref rid="feb212089-tbl-0001" ref-type="table-wrap">1</xref>. The sample produced in HEK293S cells contains residues 387â618, with 15 and 2 residues omitted from the Nâ and Câterminal transmembrane helices respectively. Residues 392â606 were modelled into the kidneyâshaped molecule that has a core comprising a fourâstranded antiparallel Î²âsheet (Î²1, Î²6, Î²9â Î²10) with one side protected by the Î±2 and Î±8 helices (Fig. <xref rid="feb212089-fig-0001" ref-type="fig">1</xref>A). The convex face of the molecule is outlined by Î±8, the Î±8âÎ²10 loop and the Î²2âÎ²3 hairpin that connects Î²1 and Î±2, while residues linking Î²5 and Î²6 and those bridging Î²6 and Î²9 form short strands, helices and loose coils stacking in the concave face of the molecule. There are four cysteines (C468, C479, C516 and C533), which are conserved in all species from yeast to human forming two pairs of disulphide bonds. C468âC479 bridges Î±3 and Î²6, while C516âC553 anchors the Î±6âÎ±7 loop to the Câterminal end of Î±7. There are seven predicted Nâlinked glycosylation sites in the molecule, all of which are glycosylated and five sites have sufficiently clear electron density that at least one glycan residue could be modelled (N478, N524, N557, N572 and N598).</p>
        <fig fig-type="Figure" xml:lang="en" id="feb212089-fig-0001" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Overall structure of <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content>. (A) Cartoon representation of <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> rainbow coloured from N (blue) to Câtermini (red). Grey spheres indicate disease mutation sites. Glycans are shown as orange sticks (labelled with black haxagons), disulphides as purple sticks. (B) The dimer in the crystallographic asymmetric unit. (C) Superimpositions of <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> (blue) with the pore domain of bacterial multidrug efflux transporter MexB (grey) and (D) with the domain 2 of MmpL11 (grey).</p>
          </caption>
          <graphic id="nlm-graphic-3" xlink:href="FEB2-590-605-g001"/>
        </fig>
        <p>There is one NPC1DC dimer in the crystallographic asymmetric unit (Fig. <xref rid="feb212089-fig-0001" ref-type="fig">1</xref>B), however, this is simply an artefact of crystal packing, since gel filtration shows that the molecule is monomeric in solution. A structural similarity search did not reveal any significant hits for the whole NPC1DC, however, the fold of the core structure (fourâstranded Î²âsheet, Î±2 and Î±8) resembles the pore forming domain of bacterial multidrug efflux transporter MexB (Fig. <xref rid="feb212089-fig-0001" ref-type="fig">1</xref>C) <xref rid="feb212089-bib-0023" ref-type="ref">23</xref> and domain 2 of MmpL11 (Fig. <xref rid="feb212089-fig-0001" ref-type="fig">1</xref>D) <xref rid="feb212089-bib-0024" ref-type="ref">24</xref> (with rmsds of 2.0 Ã for 72 C<sub>Î±</sub>s and 1.7 Ã for 71 C<sub>Î±</sub>s respectively), both are membrane proteins and have the same orientation with respect to the membrane. The direction of the Câterminal Î²10 strand and the role of residue 502 in the interaction with EBOV GP <xref rid="feb212089-bib-0025" ref-type="ref">25</xref> (Fig. <xref rid="feb212089-fig-0001" ref-type="fig">1</xref>A) imply that the Î²4âÎ²5 hairpin and the Nâterminus of Î±8 are at the membrane proximal end of NPC1DC, a similar orientation to MexB and MmpL11.</p>
      </sec>
      <sec id="feb212089-sec-0008">
        <title>Possible interaction area with NPC2</title>
        <p>In the endo/lysosome, soluble NPC2 binds cholesterol released from endocytosed lowâdensity lipoprotein and delivers it to NPC1NTD, which transports the cholesterol to the cytosol <xref rid="feb212089-bib-0004" ref-type="ref">4</xref>. During the process NPC2 interacts directly with both NPC1NTD and NPC1DC <xref rid="feb212089-bib-0003" ref-type="ref">3</xref>; diseaseâcausing mutations in NPC1DC decrease NPC2 binding <xref rid="feb212089-bib-0003" ref-type="ref">3</xref>. We modelled all seven glycosylation sites as Man9GlcNAc2 <xref rid="feb212089-bib-0010" ref-type="ref">10</xref> and mapped the disease mutations <xref rid="feb212089-bib-0026" ref-type="ref">26</xref>, <xref rid="feb212089-bib-0027" ref-type="ref">27</xref>, <xref rid="feb212089-bib-0028" ref-type="ref">28</xref>, <xref rid="feb212089-bib-0029" ref-type="ref">29</xref>, <xref rid="feb212089-bib-0030" ref-type="ref">30</xref>, <xref rid="feb212089-bib-0031" ref-type="ref">31</xref>, <xref rid="feb212089-bib-0032" ref-type="ref">32</xref> onto the structure of NPC1DC. As shown in Figs <xref rid="feb212089-fig-0001" ref-type="fig">1</xref>A and <xref rid="feb212089-fig-0002" ref-type="fig">2</xref>, apart from residues E451, K479, Y509, K576 and T674, these mutations are either buried, and hence likely to cause structural changes, or on a large glycanâfree area of the surface, which is probably involved in interactions with NPC2, K576 and T674 are at the membrane proximal end of the molecule and could alter the orientation of NPC1DC and affect the interaction with NPC2; E451, K479 and Y509, however, are glycan shielded and unlikely to interact with NPC2. Diseaseâcausing mutations at residues 404 and 518 interfere with the interaction between NPC1 and NPC2 <xref rid="feb212089-bib-0003" ref-type="ref">3</xref>.</p>
        <fig fig-type="Figure" xml:lang="en" id="feb212089-fig-0002" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>
<styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> surface mapped with <styled-content style="fixed-case">NPC</styled-content> disease mutations. (A) Man9Glc<styled-content style="fixed-case">NA</styled-content>c2 is modelled at all seven glycosylation sites of <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> with atoms shown as green spheres on the molecular surface to show glycanâfree areas on the protein. The residues mutated in <styled-content style="fixed-case">NPC</styled-content> patients are coloured in red and labelled. The molecule is shown in a similar orientation to Fig. <xref rid="feb212089-fig-0001" ref-type="fig">1</xref>A. (B) 180Â° rotation of (A) showing the back of the molecule. Residue 502, critical for <styled-content style="fixed-case">EBOV GP</styled-content> interactions is indicated by an arrow.</p>
          </caption>
          <graphic id="nlm-graphic-5" xlink:href="FEB2-590-605-g002"/>
        </fig>
      </sec>
      <sec id="feb212089-sec-0009">
        <title>Interactions between NPC1DC and EBOV GP</title>
        <p>Niemannâpick type C1 domain C is an essential receptor of all filoviruses <xref rid="feb212089-bib-0005" ref-type="ref">5</xref>. It has been reported recently that MR78, an antibody from a human survivor of MARV infection, is crossâreactive, recognizing the receptorâbinding sites of both MARV and EBOV GPs <xref rid="feb212089-bib-0033" ref-type="ref">33</xref>, <xref rid="feb212089-bib-0034" ref-type="ref">34</xref>. In addition, African strawâcoloured fruit bats whose NPC1 has a single mutation D502F are nonpermissible to EBOV infection <xref rid="feb212089-bib-0025" ref-type="ref">25</xref>. Residue 502 is at the tip of the Î²7âÎ²8 hairpin at the presumed membraneâdistal end of NPC1DC (Fig <xref rid="feb212089-fig-0001" ref-type="fig">1</xref>A). The NPC1DC Î²7âÎ²8 hairpin is remarkably similar to the Vh CDR3 of MR78 in both sequence and structure (Fig. <xref rid="feb212089-fig-0003" ref-type="fig">3</xref>). We have modelled the NPC1DCâEBOV GP complex (Fig. <xref rid="feb212089-fig-0004" ref-type="fig">4</xref>) by knowledgeâbased proteinâprotein docking. The result is supported by modelling the glycans on the surface of the NPC1DC and the viral GPs structures after receptor binding, which confirms that the binding area is glycan free. Furthermore, the released GP2 would be able to present its fusion loop to the endo/lysosome membrane (Fig. <xref rid="feb212089-fig-0005" ref-type="fig">5</xref>). While finalizing this paper, a crystal structure of NPC1DC and EBOV GP complex was published <xref rid="feb212089-bib-0035" ref-type="ref">35</xref>, in which the NPC1DC was produced in <italic>E. coli</italic>. The binding mode of the complex appears to confirm our docked complex (see below). In the docked complex the Î²7âÎ²8 hairpin binds EBOV GP with F503 and F504 nesting in a hydrophobic pocket of EBOV GP similar to F111âB and Y112âB of the Vh CRD3 of MR78 (Fig. <xref rid="feb212089-fig-0004" ref-type="fig">4</xref>B). Remarkably we find that both the Î²2âÎ²3 and Î²7âÎ²8 hairpins interact with EBOV GP by mimicking the Vh CRD3 and Vl CRD3 of MR78 (Fig. <xref rid="feb212089-fig-0004" ref-type="fig">4</xref>C). The sideâchain of D502 could hydrogenâbond to the amino group of F88 of the GP thus a phenylalanine at 502 would cause severe clashes. F504 makes direct contacts with GP V141. A V141A mutation might allow the Î²7âÎ²8 hairpin to shift, providing enough space to accommodate a phenylalanine at 502, explaining why the V141A mutation can enhance viral entry to F502 bearing cells (Ng <italic>et al</italic>. <xref rid="feb212089-bib-0025" ref-type="ref">25</xref>). Interestingly, in chickens all residues in the Î²7âÎ²8 hairpin are identical to those of primates but they are not susceptible to Ebola virus. Sequence examination reveals chickenâspecific H418D, Q421S mutations in the Î²2âÎ²3 hairpin (Fig. <xref rid="feb212089-fig-0006" ref-type="fig">6</xref>). The sideâchain of Q421 is sandwiched between the Î²2âÎ²3 hairpin and Î²7âÎ²9 sheet, possibly hydrogen bonding to either S142 or T144 depending on its conformation on complex formation. In addition, residue 418, located at the edge of a cluster of aromatic residues between the Î²2âÎ²3 and Î²7âÎ²8 hairpins, is a histidine in all species except chicken, where it is aspartic acid. This residue makes direct hydrogen bond interactions with Y509 and H510, and the H418D mutation may disturb the conformation of the two hairpins. Thus, mutations at residues 418 and 421 might abrogate EBOV glycoprotein binding.</p>
        <fig fig-type="Figure" xml:lang="en" id="feb212089-fig-0003" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Structural similarity between the Î²7âÎ²8 hairpin of <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> and the Vh <styled-content style="fixed-case">CDR</styled-content>3 of <styled-content style="fixed-case">MR</styled-content>78 antibody. (A) Î²7âÎ²8 hairpin of <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> (500 <styled-content style="fixed-case">GDDFFVY</styled-content> 506). (B) Vh <styled-content style="fixed-case">CDR</styled-content>3 of the <styled-content style="fixed-case">MR</styled-content>78 antibody (110 <styled-content style="fixed-case">SGTFYYY</styled-content> 112).</p>
          </caption>
          <graphic id="nlm-graphic-7" xlink:href="FEB2-590-605-g003"/>
        </fig>
        <fig fig-type="Figure" xml:lang="en" id="feb212089-fig-0004" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>The docked complex of <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> and <styled-content style="fixed-case">EBOV GP</styled-content>. (A) Cartoon representation of <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> (cyan) and <styled-content style="fixed-case">EBOV GP</styled-content> (<styled-content style="fixed-case">GP</styled-content>1, blue; <styled-content style="fixed-case">GP</styled-content>2, red) complex. (B) Molecular interface of <styled-content style="fixed-case">EBOV GP</styled-content> and <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content>. <styled-content style="fixed-case">GP</styled-content> is shown as an electrostatic surface, <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> as cyan ribbons with sideâchains as yellow sticks. (C) The docked <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> and <styled-content style="fixed-case">EBOV GP</styled-content> complex shows that Î²7âÎ²8 and Î²2âÎ²3 hairpins (cyan) are mimicked by interactions of the Vh <styled-content style="fixed-case">CDR</styled-content>3 and Vl <styled-content style="fixed-case">CDR</styled-content>3 (blue) of the antibody <styled-content style="fixed-case">MR</styled-content>78, respectively, with Ebola <styled-content style="fixed-case">GP</styled-content>.</p>
          </caption>
          <graphic id="nlm-graphic-9" xlink:href="FEB2-590-605-g004"/>
        </fig>
        <fig fig-type="Figure" xml:lang="en" id="feb212089-fig-0005" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <p>The putative trimeric complex of <styled-content style="fixed-case">EBOV GP</styled-content> and <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content>. (A) The docked trimetric complex of Ebola <styled-content style="fixed-case">GP</styled-content> and <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content>. <styled-content style="fixed-case">GP</styled-content>1, <styled-content style="fixed-case">GP</styled-content>2 and <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> are coloured in blue, red and cyan, respectively. Man9Glc<styled-content style="fixed-case">NA</styled-content>c2 is modelled at all glycosylation sites of <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> showing that the glycans do not hinder the formation of the complex. (B) Subsequent to receptor binding, it is proposed that <styled-content style="fixed-case">GP</styled-content>2 undergoes conformational changes. Its two helices (residues 553â597) coalesce to present the fusion loop to the endo/lysosomal membrane. The colour scheme is as in (A).</p>
          </caption>
          <graphic id="nlm-graphic-11" xlink:href="FEB2-590-605-g005"/>
        </fig>
        <fig fig-type="Figure" xml:lang="en" id="feb212089-fig-0006" orientation="portrait" position="float">
          <label>Figure 6</label>
          <caption>
            <p>Amino acid sequence alignment of the <styled-content style="fixed-case">NPC</styled-content>1<styled-content style="fixed-case">DC</styled-content> Î²2âÎ²3 and Î²7âÎ²8 hairpin regions. Alignment <styled-content style="fixed-case">of NPC</styled-content>1 <styled-content style="fixed-case">DC</styled-content> Î²2âÎ²3 and Î²7âÎ²8 hairpin regions from Human (<italic>Homo sapiens</italic>), Monkey (<italic>Rhesus macaque</italic>), Dog (<italic>Canis lupus familiaris</italic>), Bat_Eh (<italic>Ediolon helumn</italic>), Bat_Ra (<italic>Rousettus aegyptiacus</italic>), Pig (<italic>Sus scrofa</italic>), Mouse (<italic>Mus musculus</italic>) and Chicken (<italic>Gallus gallus</italic>). Names of susceptible species are coloured in red, and refractory species in green. Numbering corresponds to the full length human <styled-content style="fixed-case">NPC</styled-content>1, conserved residues are shown in a red background. Secondary structure elements are labelled on the top. The positions of H418, Q421, D502 and F504 are marked green to indicate the difference in susceptibility to Filovirus infection.</p>
          </caption>
          <graphic id="nlm-graphic-13" xlink:href="FEB2-590-605-g006"/>
        </fig>
      </sec>
    </sec>
    <sec id="feb212089-sec-0010">
      <title>Conclusion</title>
      <p>The structure of NPC1DC shows the surface area probably involved in the interactions with NPC2 broadening our understanding of cholesterol delivery to NPC1. The speciesâspecific susceptibility to EBOV infection can be explained by amino acid variations at just four residues, 418, 421, 502 and 504, all of which are located at interface of the putative complex with EBOV glycoprotein.</p>
      <p>After submission of this paper, the coordinates of the crystal structure of GPâNPC1DC complex have been released (<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F1B">5F1B</ext-link>). The overall binding mode between the GP and NPC1 in the docked complex is very similar to the crystal structure. After superimposing the GP structures the CÎ± positions of the three key receptor residues 502, 503 and 504 differ by 1.3, 1.8 and 2.2 Ã respectively.</p>
    </sec>
    <sec id="feb212089-sec-0011">
      <title>Accession codes</title>
      <p>Coordinates and structure factors have been deposited in the Protein Data Bank under accession code <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HNS">5HNS</ext-link>.</p>
    </sec>
  </body>
  <back>
    <ack id="feb212089-sec-0012">
      <title>Acknowledgements</title>
      <p>We thank Diamond scientists at I04 for assistance with data collection and Elizabeth Fry for comments on the manuscript. Y.Z. and K.H were supported by the BiostructâX project (283570) funded by the EU seventh Framework Programme (FP7), J.R. by the Wellcome Trust and D.I.S. by the UK Medical Research Council (grant MR/N00065X/1). This is a contribution from the UK Instruct Centre. The Wellcome Trust Centre for Human Genetics is supported by the Wellcome Trust (grant 090532/Z/09/Z).</p>
    </ack>
    <ref-list content-type="cited-references" id="feb212089-bibl-0001">
      <title>References</title>
      <ref id="feb212089-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0001">
<string-name>
<surname>Vanier</surname>
<given-names>MT</given-names>
</string-name> (<year>2015</year>) <article-title>Complex lipid trafficking in NiemannâPick disease type C</article-title>. <source>J Inherit Metab Dis</source>
<volume>38</volume>, <fpage>187</fpage>â<lpage>199</lpage>.<pub-id pub-id-type="pmid">25425283</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0002">
<string-name>
<surname>Willenborg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>CK</given-names>
</string-name>, <string-name>
<surname>Braun</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Landgrebe</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>von Figura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Saftig</surname>
<given-names>P</given-names>
</string-name> and <string-name>
<surname>Eskelinen</surname>
<given-names>EL</given-names>
</string-name> (<year>2005</year>) <article-title>Mannose 6âphosphate receptors, NiemannâPick C2 protein, and lysosomal cholesterol accumulation</article-title>. <source>J Lipid Res</source>
<volume>46</volume>, <fpage>2559</fpage>â<lpage>2569</lpage>.<pub-id pub-id-type="pmid">16177447</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0003">
<string-name>
<surname>Deffieu</surname>
<given-names>MS</given-names>
</string-name> and <string-name>
<surname>Pfeffer</surname>
<given-names>SR</given-names>
</string-name> (<year>2011</year>) <article-title>NiemannâPick type C 1 function requires lumenal domain residues that mediate cholesterolâdependent NPC2 binding</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>108</volume>, <fpage>18932</fpage>â<lpage>18936</lpage>.<pub-id pub-id-type="pmid">22065762</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0004">
<string-name>
<surname>Kwon</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>AbiâMosleh</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Deisenhofer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>MS</given-names>
</string-name> and <string-name>
<surname>Infante</surname>
<given-names>RE</given-names>
</string-name> (<year>2009</year>) <article-title>Structure of Nâterminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol</article-title>. <source>Cell</source>
<volume>137</volume>, <fpage>1213</fpage>â<lpage>1224</lpage>.<pub-id pub-id-type="pmid">19563754</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0005">
        <label>5</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0005">
<string-name>
<surname>Carette</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Raaben</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Herbert</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Obernosterer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mulherkar</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kuehne</surname>
<given-names>AI</given-names>
</string-name>, <string-name>
<surname>Kranzusch</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Griffin</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Ruthel</surname>
<given-names>G</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Ebola virus entry requires the cholesterol transporter NiemannâPick C1</article-title>. <source>Nature</source>
<volume>477</volume>, <fpage>340</fpage>â<lpage>343</lpage>.<pub-id pub-id-type="pmid">21866103</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0006">
        <label>6</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0006">
<string-name>
<surname>Cote</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Misasi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bruchez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Filone</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Hensley</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Ory</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chandran</surname>
<given-names>K</given-names>
</string-name>
<italic>et al</italic> (<year>2011</year>) <article-title>Small molecule inhibitors reveal NiemannâPick C1 is essential for Ebola virus infection</article-title>. <source>Nature</source>
<volume>477</volume>, <fpage>344</fpage>â<lpage>348</lpage>.<pub-id pub-id-type="pmid">21866101</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0007">
        <label>7</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0007">
<string-name>
<surname>Safari</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Baratloo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rouhipour</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ghelichkhani</surname>
<given-names>P</given-names>
</string-name> and <string-name>
<surname>Yousefifard</surname>
<given-names>M</given-names>
</string-name> (<year>2015</year>) <article-title>Ebola hemorrhagic fever as a public health emergency of international concern; a review article</article-title>. <source>Emergency</source>
<volume>3</volume>, <fpage>3</fpage>â<lpage>7</lpage>.<pub-id pub-id-type="pmid">26512362</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0008">
        <label>8</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0008">
<string-name>
<surname>Sakurai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kolokoltsov</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Tidwell</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Bauta</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Klugbauer</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Grimm</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>WahlâSchott</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Biel</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Davey</surname>
<given-names>RA</given-names>
</string-name> (<year>2015</year>) Ebola virus. <article-title>Twoâpore channels control Ebola virus host cell entry and are drug targets for disease treatment</article-title>. <source>Science</source>
<volume>347</volume>, <fpage>995</fpage>â<lpage>998</lpage>.<pub-id pub-id-type="pmid">25722412</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0009">
        <label>9</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0009">
<string-name>
<surname>Hacke</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Bjorkholm</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hellwig</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Himmels</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>de Almodovar</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Brugger</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Wieland</surname>
<given-names>F</given-names>
</string-name> and <string-name>
<surname>Ernst</surname>
<given-names>AM</given-names>
</string-name> (<year>2015</year>) <article-title>Inhibition of Ebola virus glycoproteinâmediated cytotoxicity by targeting its transmembrane domain and cholesterol</article-title>. <source>Nat Commun</source>
<volume>6</volume>, <fpage>7688</fpage>.<pub-id pub-id-type="pmid">26158910</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0010">
        <label>10</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0010">
<string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>PadillaâParra</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fry</surname>
<given-names>EE</given-names>
</string-name> and <string-name>
<surname>Stuart</surname>
<given-names>DI</given-names>
</string-name> (<year>2014</year>) <article-title>Lysosome sorting of betaâglucocerebrosidase by LIMPâ2 is targeted by the mannose 6âphosphate receptor</article-title>. <source>Nat Commun</source>
<volume>5</volume>, <fpage>4321</fpage>.<pub-id pub-id-type="pmid">25027712</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0011">
        <label>11</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0011">
<string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bishop</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Clay</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Daenke</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Siebold</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Stuart</surname>
<given-names>DI</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>EY</given-names>
</string-name> and <string-name>
<surname>Aricescu</surname>
<given-names>AR</given-names>
</string-name> (<year>2011</year>) <article-title>Automation of large scale transient protein expression in mammalian cells</article-title>. <source>J Struct Biol</source>
<volume>175</volume>, <fpage>209</fpage>â<lpage>215</lpage>.<pub-id pub-id-type="pmid">21571074</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0012">
        <label>12</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0012">
<string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Malinauskas</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Harlos</surname>
<given-names>K</given-names>
</string-name> and <string-name>
<surname>Jones</surname>
<given-names>EY</given-names>
</string-name> (<year>2014</year>) <article-title>Structural insights into the inhibition of Wnt signaling by cancer antigen 5T4/Wntâactivated inhibitory factor 1</article-title>. <source>Structure</source>
<volume>22</volume>, <fpage>612</fpage>â<lpage>620</lpage>.<pub-id pub-id-type="pmid">24582434</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0013">
        <label>13</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0013">
<string-name>
<surname>Walter</surname>
<given-names>TS</given-names>
</string-name>, <string-name>
<surname>Mancini</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Kadlec</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Graham</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Assenberg</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sainsbury</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Owens</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Stuart</surname>
<given-names>DI</given-names>
</string-name>, <string-name>
<surname>Grimes</surname>
<given-names>JM</given-names>
</string-name>
<italic>et al</italic> (<year>2008</year>) <article-title>Semiâautomated microseeding of nanolitre crystallization experiments</article-title>. <source>Acta Crystallogr Sect F Struct Biol Cryst Commun</source>
<volume>64</volume>, <fpage>14</fpage>â<lpage>18</lpage>.</mixed-citation>
      </ref>
      <ref id="feb212089-bib-0014">
        <label>14</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0014">
<string-name>
<surname>Winter</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lobley</surname>
<given-names>CM</given-names>
</string-name> and <string-name>
<surname>Prince</surname>
<given-names>SM</given-names>
</string-name> (<year>2013</year>) <article-title>Decision making in xia2</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source>
<volume>69</volume>, <fpage>1260</fpage>â<lpage>1273</lpage>.<pub-id pub-id-type="pmid">23793152</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0015">
        <label>15</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0015">
<string-name>
<surname>Pape</surname>
<given-names>T</given-names>
</string-name> and <string-name>
<surname>Schneider</surname>
<given-names>TR</given-names>
</string-name> (<year>2004</year>) <article-title>HKL2MAP: a graphical user interface for macromolecular phasing with SHELX programs</article-title>. <source>J Appl Crystallogr</source>
<volume>37</volume>, <fpage>843</fpage>â<lpage>844</lpage>.</mixed-citation>
      </ref>
      <ref id="feb212089-bib-0016">
        <label>16</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0016">
<string-name>
<surname>Adams</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Afonine</surname>
<given-names>PV</given-names>
</string-name>, <string-name>
<surname>Bunkoczi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>VB</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>IW</given-names>
</string-name>, <string-name>
<surname>Echols</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Headd</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Hung</surname>
<given-names>LW</given-names>
</string-name>, <string-name>
<surname>Kapral</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>GrosseâKunstleve</surname>
<given-names>RW</given-names>
</string-name>
<italic>et al</italic> (<year>2010</year>) <article-title>PHENIX: a comprehensive Pythonâbased system for macromolecular structure solution</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source>
<volume>66</volume>, <fpage>213</fpage>â<lpage>221</lpage>.<pub-id pub-id-type="pmid">20124702</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0017">
        <label>17</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0017">
<string-name>
<surname>Winn</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Murshudov</surname>
<given-names>GN</given-names>
</string-name> and <string-name>
<surname>Papiz</surname>
<given-names>MZ</given-names>
</string-name> (<year>2003</year>) <article-title>Macromolecular TLS refinement in REFMAC at moderate resolutions</article-title>. <source>Methods Enzymol</source>
<volume>374</volume>, <fpage>300</fpage>â<lpage>321</lpage>.<pub-id pub-id-type="pmid">14696379</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0018">
        <label>18</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0018">
<string-name>
<surname>Emsley</surname>
<given-names>P</given-names>
</string-name> and <string-name>
<surname>Cowtan</surname>
<given-names>K</given-names>
</string-name> (<year>2004</year>) <article-title>Coot: modelâbuilding tools for molecular graphics</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source>
<volume>60</volume>, <fpage>2126</fpage>â<lpage>2132</lpage>.<pub-id pub-id-type="pmid">15572765</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0019">
        <label>19</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0019">
<string-name>
<surname>Lee</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Fusco</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Hessell</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Oswald</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Burton</surname>
<given-names>DR</given-names>
</string-name> and <string-name>
<surname>Saphire</surname>
<given-names>EO</given-names>
</string-name> (<year>2008</year>) <article-title>Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor</article-title>. <source>Nature</source>
<volume>454</volume>, <fpage>177</fpage>â<lpage>182</lpage>.<pub-id pub-id-type="pmid">18615077</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0020">
        <label>20</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0020">
<string-name>
<surname>Kastritis</surname>
<given-names>PL</given-names>
</string-name>, <string-name>
<surname>Rodrigues</surname>
<given-names>JP</given-names>
</string-name> and <string-name>
<surname>Bonvin</surname>
<given-names>AM</given-names>
</string-name> (<year>2014</year>) <article-title>HADDOCK(2P2I): a biophysical model for predicting the binding affinity of proteinâprotein interaction inhibitors</article-title>. <source>J Chem Inf Model</source>
<volume>54</volume>, <fpage>826</fpage>â<lpage>836</lpage>.<pub-id pub-id-type="pmid">24521147</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0021">
        <label>21</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0021">
<string-name>
<surname>Tovchigrechko</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Vakser</surname>
<given-names>IA</given-names>
</string-name> (<year>2006</year>) <article-title>GRAMMâX public web server for proteinâprotein docking</article-title>. <source>Nucleic Acids Res</source>
<volume>34</volume>, <fpage>W310</fpage>â<lpage>W314</lpage>.<pub-id pub-id-type="pmid">16845016</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0022">
        <label>22</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0022">
<string-name>
<surname>DeLano</surname>
<given-names>WL</given-names>
</string-name> and <string-name>
<surname>Lam</surname>
<given-names>JW</given-names>
</string-name> (<year>2005</year>) <article-title>PyMOL: a communications tool for computational models</article-title>. <source>Abstr Pap Am Chem S</source>
<volume>230</volume>, <fpage>U1371</fpage>â<lpage>U1372</lpage>.</mixed-citation>
      </ref>
      <ref id="feb212089-bib-0023">
        <label>23</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0023">
<string-name>
<surname>Nakashima</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Sakurai</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yamasaki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hayashi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nagata</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hoshino</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Onodera</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nishino</surname>
<given-names>K</given-names>
</string-name> and <string-name>
<surname>Yamaguchi</surname>
<given-names>A</given-names>
</string-name> (<year>2013</year>) <article-title>Structural basis for the inhibition of bacterial multidrug exporters</article-title>. <source>Nature</source>
<volume>500</volume>, <fpage>102</fpage>â<lpage>106</lpage>.<pub-id pub-id-type="pmid">23812586</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0024">
        <label>24</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0024">
<string-name>
<surname>Chim</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Torres</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Capri</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Batot</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Whitelegge</surname>
<given-names>JP</given-names>
</string-name> and <string-name>
<surname>Goulding</surname>
<given-names>CW</given-names>
</string-name> (<year>2015</year>) <article-title>The Structure and interactions of periplasmic domains of crucial MmpL membrane proteins from <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Chem Biol</source>
<volume>22</volume>, <fpage>1098</fpage>â<lpage>1107</lpage>.<pub-id pub-id-type="pmid">26278184</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0025">
        <label>25</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0025">
<string-name>
<surname>Ng</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ndungo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kaczmarek</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Herbert</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Binger</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kuehne</surname>
<given-names>AI</given-names>
</string-name>, <string-name>
<surname>Jangra</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Hawkins</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Gifford</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Biswas</surname>
<given-names>R</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Filovirus receptor NPC1 contributes to speciesâspecific patterns of ebolavirus susceptibility in bats</article-title>. <source>eLife</source>
<volume>4</volume>, pii: <fpage>e11785</fpage>.<pub-id pub-id-type="pmid">26698106</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0026">
        <label>26</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0026">
<string-name>
<surname>FernandezâValero</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Ballart</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Iturriaga</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lluch</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Macias</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Vanier</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Pineda</surname>
<given-names>M</given-names>
</string-name> and <string-name>
<surname>Coll</surname>
<given-names>MJ</given-names>
</string-name> (<year>2005</year>) <article-title>Identification of 25 new mutations in 40 unrelated Spanish NiemannâPick type C patients: genotypeâphenotype correlations</article-title>. <source>Clin Genet</source>
<volume>68</volume>, <fpage>245</fpage>â<lpage>254</lpage>.<pub-id pub-id-type="pmid">16098014</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0027">
        <label>27</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0027">
<string-name>
<surname>Millat</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Marcais</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tomasetto</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chikh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fensom</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Harzer</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wenger</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Ohno</surname>
<given-names>K</given-names>
</string-name> and <string-name>
<surname>Vanier</surname>
<given-names>MT</given-names>
</string-name> (<year>2001</year>) <article-title>NiemannâPick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterolâsensing domain and of the cysteineârich luminal loop</article-title>. <source>Am J Hum Genet</source>
<volume>68</volume>, <fpage>1373</fpage>â<lpage>1385</lpage>.<pub-id pub-id-type="pmid">11333381</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0028">
        <label>28</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0028">
<string-name>
<surname>Park</surname>
<given-names>WD</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Lundquist</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Kraft</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Vockley</surname>
<given-names>CW</given-names>
</string-name>, <string-name>
<surname>Karnes</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Patterson</surname>
<given-names>MC</given-names>
</string-name> and <string-name>
<surname>Snow</surname>
<given-names>K</given-names>
</string-name> (<year>2003</year>) <article-title>Identification of 58 novel mutations in NiemannâPick disease type C: correlation with biochemical phenotype and importance of PTC1âlike domains in NPC1</article-title>. <source>Hum Mutat</source>
<volume>22</volume>, <fpage>313</fpage>â<lpage>325</lpage>.<pub-id pub-id-type="pmid">12955717</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0029">
        <label>29</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0029">
<string-name>
<surname>Ribeiro</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Marcao</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Amaral</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Sa Miranda</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Vanier</surname>
<given-names>MT</given-names>
</string-name> and <string-name>
<surname>Millat</surname>
<given-names>G</given-names>
</string-name> (<year>2001</year>) <article-title>NiemannâPick type C disease: NPC1 mutations associated with severe and mild cellular cholesterol trafficking alterations</article-title>. <source>Hum Genet</source>
<volume>109</volume>, <fpage>24</fpage>â<lpage>32</lpage>.<pub-id pub-id-type="pmid">11479732</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0030">
        <label>30</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0030">
<string-name>
<surname>Sun</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Marks</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>WD</given-names>
</string-name>, <string-name>
<surname>Wheatley</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Puri</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Kraft</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Lundquist</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Patterson</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Pagano</surname>
<given-names>RE</given-names>
</string-name>
<italic>et al</italic> (<year>2001</year>) <article-title>NiemannâPick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1</article-title>. <source>Am J Hum Genet</source>
<volume>68</volume>, <fpage>1361</fpage>â<lpage>1372</lpage>.<pub-id pub-id-type="pmid">11349231</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0031">
        <label>31</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0031">
<string-name>
<surname>Tarugi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ballarini</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bembi</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Battisti</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Palmeri</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Panzani</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Di Leo</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Martini</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Federico</surname>
<given-names>A</given-names>
</string-name> and <string-name>
<surname>Calandra</surname>
<given-names>S</given-names>
</string-name> (<year>2002</year>) <article-title>NiemannâPick type C disease: mutations of NPC1 gene and evidence of abnormal expression of some mutant alleles in fibroblasts</article-title>. <source>J Lipid Res</source>
<volume>43</volume>, <fpage>1908</fpage>â<lpage>1919</lpage>.<pub-id pub-id-type="pmid">12401890</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0032">
        <label>32</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0032">
<string-name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ninomiya</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Matsumoto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ohta</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nanba</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tsutsumi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yamakawa</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Millat</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Vanier</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Pentchev</surname>
<given-names>PG</given-names>
</string-name>
<italic>et al</italic> (<year>2000</year>) <article-title>Genotypeâphenotype relationship of NiemannâPick disease type C: a possible correlation between clinical onset and levels of NPC1 protein in isolated skin fibroblasts</article-title>. <source>J Med Genet</source>
<volume>37</volume>, <fpage>707</fpage>â<lpage>712</lpage>.<pub-id pub-id-type="pmid">11182931</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0033">
        <label>33</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0033">
<string-name>
<surname>Flyak</surname>
<given-names>AI</given-names>
</string-name>, <string-name>
<surname>Ilinykh</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Murin</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Garron</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Fusco</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Hashiguchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bornholdt</surname>
<given-names>ZA</given-names>
</string-name>, <string-name>
<surname>Slaughter</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Sapparapu</surname>
<given-names>G</given-names>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Mechanism of human antibodyâmediated neutralization of Marburg virus</article-title>. <source>Cell</source>
<volume>160</volume>, <fpage>893</fpage>â<lpage>903</lpage>.<pub-id pub-id-type="pmid">25723164</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0034">
        <label>34</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0034">
<string-name>
<surname>Hashiguchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fusco</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Bornholdt</surname>
<given-names>ZA</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Flyak</surname>
<given-names>AI</given-names>
</string-name>, <string-name>
<surname>Matsuoka</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kohda</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Yanagi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hammel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Crowe</surname>
<given-names>JE</given-names>
<suffix>Jr</suffix>
</string-name>
<italic>et al</italic> (<year>2015</year>) <article-title>Structural basis for Marburg virus neutralization by a crossâreactive human antibody</article-title>. <source>Cell</source>
<volume>160</volume>, <fpage>904</fpage>â<lpage>912</lpage>.<pub-id pub-id-type="pmid">25723165</pub-id></mixed-citation>
      </ref>
      <ref id="feb212089-bib-0035">
        <label>35</label>
        <mixed-citation publication-type="journal" id="feb212089-cit-0035">
<string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Qi</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>J</given-names>
</string-name> and <string-name>
<surname>Gao</surname>
<given-names>GF</given-names>
</string-name> (<year>2016</year>) <article-title>Ebola viral glycoprotein bound to its endosomal receptor NiemannâPick C1</article-title>. <source>Cell</source>
<volume>164</volume>, <fpage>258</fpage>â<lpage>268</lpage>.<pub-id pub-id-type="pmid">26771495</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>